These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34985532)

  • 1. Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation.
    Gibson AS; West PJ; Keefe KA
    Psychopharmacology (Berl); 2022 Jan; 239(1):93-104. PubMed ID: 34985532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
    Friend DM; Keefe KA
    Neurosci Lett; 2013 Oct; 555():243-7. PubMed ID: 23994061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optogenetic induction of orbitostriatal long-term potentiation in the dorsomedial striatum elicits a persistent reduction of alcohol-seeking behavior in rats.
    Cheng Y; Xie X; Lu J; Gangal H; Wang W; Melo S; Wang X; Jerger J; Woodson K; Garr E; Huang Y; Janak P; Wang J
    Neuropharmacology; 2021 Jun; 191():108560. PubMed ID: 33894220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
    Howard CD; Keefe KA; Garris PA; Daberkow DP
    J Neurochem; 2011 Aug; 118(4):668-76. PubMed ID: 21668447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
    Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
    Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired formation of stimulus-response, but not action-outcome, associations in rats with methamphetamine-induced neurotoxicity.
    Son JH; Latimer C; Keefe KA
    Neuropsychopharmacology; 2011 Nov; 36(12):2441-51. PubMed ID: 21775980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol attenuates the HFS-induced, ERK-mediated LTP in a dose-dependent manner in rat striatum.
    Xie GQ; Wang SJ; Li J; Cui SZ; Zhou R; Chen L; Yuan XR
    Alcohol Clin Exp Res; 2009 Jan; 33(1):121-8. PubMed ID: 18945217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
    Miller DB; O'Callaghan JP; Ali SF
    Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH23390 Reduces Methamphetamine Self-Administration and Prevents Methamphetamine-Induced Striatal LTD.
    Avchalumov Y; Trenet W; Piña-Crespo J; Mandyam C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.
    Friend DM; Son JH; Keefe KA; Fricks-Gleason AN
    J Pharmacol Exp Ther; 2013 Feb; 344(2):511-21. PubMed ID: 23230214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
    Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
    Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
    Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
    Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus.
    Swant J; Chirwa S; Stanwood G; Khoshbouei H
    PLoS One; 2010 Jun; 5(6):e11382. PubMed ID: 20614033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
    Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
    J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
    Park SW; Shen X; Tien LT; Roman R; Ma T
    J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2008 Jul; 106(2):696-705. PubMed ID: 18410508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.